RDY Dividend: Dr Reddy's Laboratories Ltd Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

RDY Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
Revenue	343,100	326,439	280,111	246,697	215,452	190,475
Revenue Growth (YoY)	14%	17%	14%	15%	13%	9%
Cost of Revenue	113,627	107,834	89,398	83,048	79,972	65,647
Gross Profit	229,473	218,605	190,713	163,649	135,480	124,828
Selling, General & Admin	78,833	107,560	92,026	82,048	73,399	63,851
Research & Development	--	23,881	19,353	16,201	15,100	15,468
Operating Expenses	162,155	148,478	126,079	110,751	100,151	91,607
Other Non Operating Income (Expenses)	12,461	1,908	2,342	6,289	657	421
Pretax Income	75,293	76,795	72,010	60,485	30,614	28,835
Income Tax Expense	17,917	19,543	16,231	15,412	8,833	9,632
Net Income	57,722	56,551	55,779	45,073	21,825	19,516
Net Income Growth	8%	1%	24%	107%	12%	-4%
Shares Outstanding (Diluted)	833.08	834.17	833.53	831.94	831.69	166
Shares Change (YoY)	0%	0%	0%	0%	401%	0%
EPS (Diluted)	69.28	67.79	66.91	54.17	26.24	117.56
EPS Growth	8%	1%	24%	106%	-78%	-4%
Free Cash Flow	18,472	12,030	17,998	40,009	9,059	23,142
Free Cash Flow Per Share	22.17	14.42	21.59	48.09	10.89	139.4
Gross Margin	66.88%	66.96%	68.08%	66.33%	62.88%	65.53%
Operating Margin	19.62%	21.48%	23.07%	21.44%	16.39%	17.44%
Profit Margin	16.82%	17.32%	19.91%	18.27%	10.12%	10.24%
Free Cash Flow Margin	5.38%	3.68%	6.42%	16.21%	4.2%	12.14%
EBITDA	86,386	87,164	79,334	65,400	46,981	45,509
EBITDA Margin	25.17%	26.7%	28.32%	26.51%	21.8%	23.89%
D&A For EBITDA	19,068	17,037	14,700	12,502	11,652	12,288
EBIT	67,318	70,127	64,634	52,898	35,329	33,221
EBIT Margin	19.62%	21.48%	23.07%	21.44%	16.39%	17.44%
Effective Tax Rate	23.79%	25.44%	22.53%	25.48%	28.85%	33.4%